Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 16:00:49 2026-01-13 EST			5-day change	1st Jan Change
108.26 ^USD	-0.85%		-0.56%	+2.85%

01-13	Illumina Announces Alliance Framework with AstraZeneca, Merck, and Eli Lilly and Company	CI
01-13	Illumina introduces Billion Cell Atlas, genome-wide genetic perturbation dataset	RE

Analyst Reco.

01-09	Morgan Stanley Adjusts Price Target on Merck to $101 From $102, Maintains Equalweight Rating	MT
01-09	Morgan Stanley Trims Price Target on Merck to $101 From $102, Keeps Equalweight Rating	MT
01-08	Merck Shares Rise After Wolfe Research Upgrade	MT
01-08	Rothschild & Co Redburn Adjusts Merck Price Target to $135 From $125, Maintains Buy Rating	MT
01-08	Wolfe Research Upgrades Merck & Co. to Outperform From Peer Perform, Price Target is $135	MT
01-07	UBS Adjusts Price Target on Merck & Co to $130 From $105, Maintains Buy Rating	MT
01-05	Exelixis Faces Limited High-Impact Catalysts, BofA Says	MT
12-18	BMO Capital Upgrades Merck & Co. to Outperform From Market Perform, Adjusts PT to $130 From $82	MT
12-18	Analyst recommendations: American Express, Merck, Rivian, Albemarle, Micron…
12-17	Deutsche Bank Adjusts Price Target on Merck to $115 From $111, Maintains Hold Rating	MT
12-15	Merck Poised for Mid-Single-Digit Revenue Growth in Fiscal 2026, BofA Says	MT
12-12	Morgan Stanley Adjusts Merck & Co. PT to $102 From $100, Maintains Equalweight Rating	MT
12-10	HSBC Adjusts Price Target on Merck & Co. to $120 From $100, Maintains Buy Rating	MT
12-05	Guggenheim Adjusts Price Target on Merck & Co. to $122 From $104, Maintains Buy Rating	MT
12-04	Scotiabank Adjusts Price Target on Merck & Co to $120 From $105, Maintains Sector Outperform Rating	MT
12-01	Goldman Sachs Adjusts Price Target on Merck to $120 From $92, Maintains Buy Rating	MT
11-24	Wells Fargo Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $125 From $90	MT
11-19	Berenberg Adjusts Price Target on Merck & Co. to $95 From $90, Maintains Hold Rating	MT
11-19	Rothschild & Co Redburn Adjusts Price Target on Merck & Co. to $125 From $120, Maintains Buy Rating	MT
11-19	Berenberg Raises Price Target on Merck to $95 From $90, Keeps Hold Rating	MT
11-19	Jefferies Adjusts Price Target on Merck & Co. to $139 From $138, Maintains Buy Rating	MT
11-18	Deutsche Bank Lifts Price Target on Merck to $111 From $110, Keeps Hold Rating	MT
11-17	Sector Update: Health Care Stocks Softer Late Afternoon	MT
11-17	Jefferies Adjusts Price Target on Merck & Co. to $138 From $137, Maintains Buy Rating	MT
11-13	Scotiabank Initiates Merck & Co. at Sector Outperform With $105 Price Target	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Merck to Buy Verona Pharma for About $10B

July 09, 2025 at 12:30 pm